Physical Activity Levels and Associated Factors in a Latin American COPD Population of Patients. The LASSYC Study. (4th July 2021)

• Record Type: Journal Article
• Authors: Mendoza, Laura; de Oca, María Montes; López Varela, María Victorina; Casas, Alejandro; Ramírez-Venegas, Alejandra; López, Ana; Ugalde, Luis; Wehrmeister, Fernando C.; Surmonti, Filip; Menezes, Ana M. B.; Miravitlles, Marc
• Is Part Of: COPD. Volume 18:Number 4(2021)
• Page Start: 393
• Page End: 400
• Publication Date: 2021-07-04
• Subjects: Physical activity -- COPD -- Latin America; Lungs -- Diseases, Obstructive -- Periodicals; 616.24
• DOI: 10.1080/15412555.2021.1937090
• Languages: English
• ISSNs: 1541-2555

Abstract

Abstract: Reduced physical activity (PA) is an independent risk factor for lung function decline, hospitalization and mortality in chronic obstructive pulmonary disease (COPD) and affects a large proportion of patients from Europe and the United States. However, little is known of the level of PA of COPD patients in Latin America. The aim of this study was to provide information of the level of PA and its determinants in COPD patients in Latin America. This is an observational, cross-sectional study on patients with COPD in seven Latin American countries. PA level was evaluated with the short version of the International Physical Activity Questionnaire (IPAQ) and the association between PA and other variables was investigated. Complete information of PA level was obtained in 734 COPD patients consecutively recruited from specialized outpatient clinics; 448 (61%) were men, with a mean age of 69.6 years (standard deviation [SD] = 8.7) and a mean FEV1 (% predicted) = 49.1% (17.5%). In 37.9% the level of PA was low, and the average sitting time was 36.1 h per week. Patients with low levels of PA were older, with higher levels of dyspnea and higher CAT scores. Additionally, we found that patients with low level of PA presented more symptoms during the day. Low levels of PA have been observed in a large proportion of COPD patients of Latin America, which is higher in women and older patients and it is related with worse functional and clinical characteristics.